Following a November 2024 FDA Advisory Committee meeting, drug injury lawsuits against AstraZeneca concerning Andexxa blood clot cases for patients who developed a pulmonary embolism (PE) or deep vein thrombosis (DVT) are likely to be filed. Of course, these Andexxa blood clot cases would have to … More
Main Navigation Menu
➤ Current Drug Injury Lawsuits / Pharmaceutical Litigations
➤ Drug Injury Case Evaluation – Free. Confidential. No Obligation.
➤ Information About the Law Offices of Thomas J. Lamb
➤ Questions New Clients Have Asked Us (FAQs)
➤ Patient Resources: Medical Sites and More
➤ Recent Side Effects Blog Articles
➤ Collection of Earlier Blog Articles
To save time, you can use our Quick Contact Form to tell us about your possible case.
Recent News & Case Reports
Ozempic Linked to Vision Loss With Increased Risk of NAION Side Effect
There is a significant development concerning semaglutide drugs like Ozempic linked to vision loss and blindness: The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes drug Ozempic to a rare eye disease. The studies published … More
Ocaliva FDA Drug Safety Warning December 2024
An Ocaliva FDA drug safety warning was issued by the FDA in December 2024 that pointed out cases of liver transplants and liver-related deaths among patients without pre-existing cirrhosis who used Ocaliva as a treatment for primary biliary cholangitis (PBC). To provide context for this most … More
Andexxa Blood Clots and Clotting-Related Deaths: FDA November 2024
The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee recently discussed the increased risk of Andexxa blood clots and clotting-related deaths seen in the ANNEXA-I trial done for Andexxa, compared with a standard of care reversal agent. This Andexxa Advisory Committee considered the … More
Brain Tumors From Birth Control Depo-Provera Injections
Brain tumors from birth control Depo-Provera injections are a drug safety issue that has resulted in some drug injury lawsuits being filed against the responsible pharmaceutical companies. A medical journal article published in March 2024 reported that Depo-Provera contraceptive injections … More
No Federal Preemption for Fosamax MDL Femur Fracture Lawsuits: September 2024 Update
The United States Court of Appeals for the Third Circuit recently issued this opinion, In re: Fosamax (alendronate sodium) Products Liability Litigation, No. 22-3412, (3d Cir. Sept. 20, 2024), ruling that there is no federal preemption for more than 500 Fosamax MDL femur fracture lawsuits that had … More